USANZ 2026, in its 30th year, offers fresh and exciting opportunities for continuing professional development offered by national and international experts.
Highlights of the program that pertain to Bladder Cancer, or selected related issues, or are presented or chaired by our co-founder and co-chair, Professor Nathan Lawrentschuk and former board member Shane Qin, include:Saturday, 28th February – workshops
- Robotic surgery (am)
- Reconstructive urology and transition care: old problems but new solutions (am)
- Incontinence: a multidisciplinary stepwise approach (am)
- Female and functional urology: contemporary advances (am)
- Ultrasounds (pm)
- Robotic surgery – prostate and pelvic oncology (pm)
- Masterclass in genital and retroperitoneal pathology: surgical precision and oncologic insight *Chaired by Prof. Nathan Lawrentschuk (13:00-16:00)
Sunday, 1st March
- Bladder Cancer: NIMBC, MIBC, adjuvant therapy: what are the recent advances? (7:00-7:45)
- Frailty and surgical outcomes in older adults (10:45-10:55)
- Can PSMA PET help select patients for active surveillance? The CONFIRM study *Presented by Prof Nathan Lawrentschuk (11:50-12:00)
- Urology in Practice – AI scribes – helping or hindering? *Presented by Prof Nathan Lawrentschuk (13:30-13:35)
- Movember and PCOR *Speaker Prof Nathan Lawrentschuk (13:50-14:05)
- Pre-cystoscopy urine culture in asymptomatic patients: a systematic review and meta-analysis (13:55-14:00)
- The clinical integration of ChatGPT through and augmented patient encounter in a real-world urological cohort (16:00-16:05) *Poster/abstract presentation by Shane Qin.
- Australian specialist cancer nursing workforce practices – findings from a national survey (14:20-14:30)
- BCG delivery in the bush: overcoming rural disparity at its best (14:40-14:50)
- Bladder Cancer SIG Meeting (15:00-15:30)
- The role of specialist nurse in coordinating complex care of cancer patients with an intellectual disability: a case study (15:40-15:50)
Monday, 2nd March
- Perioperative care and surgery in the elderly: optimization of outcomes (7:00-7:45)
Oncology – Urothelial Concurrent Session
- Why combination BCG and MMC should replace BCG alone in high risk nMIBC (16:00-16:07)
- Techniques to improve outcomes in radical cystectomy (16:07-16:15)
- TURBT techniques in 2025 (16:16-16:23)
- Discussion (16:24-16:30)
- Can Cxbladder triage be used to reduce the burden of haematuria referrals: insights from a prospective Australian trial (16:30-16:35)
- Identifying HSP90 as a therapeutic target in BCG-refractory disease (16:35-16:40)
- Open bladder cuff excision versus pluck technique in nephroureterectomy for UTUC: postoperative and oncological outcomes from an Australian Tertiary Hospital (16:40-16:45)
- Extended vs standard pelvic lymph node dissection in bladder cancer patients undergoing radical cystectomy: systematic review and meta- analysis (16:45-16:50)
- Real-world costs and impact on quality of life for CxMonitor as an alternative to flexible cystoscopy – multi-centre experience (16:50-16:55)
- Predictors of pathological upstaging from TURBT at radical cystectomy: a single-centre retrospective analysis (16:55-17:00)
- Optimising operative performance in robotic-assisted cystectomy: the role of a dual-surgeon approach and analysis of per-operative outcomes (17:00-17:05)
- Patterns of treatment and survival outcomes in bladder cancer: a population-based cohort study from New Zealand (2006-2022) (17:05-17:10)
- Multi-centre comparison of CxMonitor, a urinary biomarker, with gold-standard flexible cystoscopy in bladder cancer surveillance (17:10-17:15)
- YouTube as a source of patient information for non-metastatic muscle invasive bladder cancer (17:15-17:20)
- Streamlined BCG in a rural hospital setting – safety, efficacy and cost effectiveness (17:20-17:25)
- Impact of age on radical cystectomy outcomes for bladder cancer in an Australian cohort (17:25-17:30).
Tuesday, 3rd March
- Robotic cystectomy – tips and tricks (9:45-9:55)
- Value-based healthcare with emerging technology in urology (11:05-11:15)
Presenters / chairs: Prof. Nathan Lawrentschuk, Shane Qin (as indicated).